Benefits of an oxygen reservoir cannula versus a conventional nasal cannula during exercise in hypoxemic COPD patients: A crossover trial

Respiration

Volumn 88, Issue 5, 2014, Pages 399-405

  Gloeckl, Rainer ^a   Heinzelmann, Inga ^a   Matthaei, Maximilian ^b   Seeberg, Stella ^a   Damisch, Thomas ^a   Jerrentrup, Andreas ^b   Kenn, Klaus ^a  

^a Schoen Klinik Berchtesgadener Land   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Chronic obstructive pulmonary disease; Long term oxygen therapy; Nasal cannula; Oxymizer

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MUSCARINIC RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CYCLING; DYSPNEA; ENDURANCE; EXERCISE; FEMALE; FLOW RATE; FORCED EXPIRATORY VOLUME; HUMAN; HYPOXEMIA; MALE; NASAL CANNULA; OXYGEN NASAL CANNULA; OXYGEN RESERVOIR CANNULA; OXYGEN SATURATION; OXYGEN THERAPY; PRIORITY JOURNAL; PULMONARY REHABILITATION; TOTAL LUNG CAPACITY; ANOXIA; CATHETER; COMPLICATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICES; EQUIPMENT DESIGN; EXERCISE TOLERANCE; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIAL;

AGED; ANOXIA; CATHETERS; CROSS-OVER STUDIES; EQUIPMENT DESIGN; EXERCISE; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84928066336     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000368165     Document Type: Article

References (26)

1. GOLD Global Strategy of the diagnosis, management, and prevention of chronic obstructive pulmonary disease, updated February 2013.www.goldcopd.org (accessed 03.05.2013).
2. Koehler U, Hildebrandt O, Jerrentrup L, Koehler KI, Kianinejad P, Sohrabi K, et al: Long-term oxygen therapy (LTOT)-what should physicians, homecare-providers and health insurance companies know? Pneumologie 2014; 68: 193-198.
3. Nocturnal Oxygen Therapy Trial Group: Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial .Ann Intern Med 1980; 93: 391-398.
4. Report of the Medical Research Council Working Party: Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema.Lancet 1981; 1: 681-686.
5. Vogiatzis I, Athanasopoulos D, Stratakos G, Garagouni C, Koutsoukou A, Boushel R, et al: Exercise-induced skeletal muscle deoxygenation in O-supplemented COPD patients .Scand J Med Sci Sports 2009; 19: 364-372.
6. O'Donnell DE, D'Arsigny C, Webb KA: Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease .Am J Respir Crit Care Med 2001; 163: 892-898.
7. Woodcock AA, Gross ER, Geddes DM: Oxygen relieves breathlessness in 'pink puffers' .Lancet 1981; 1: 907-909.
8. Gloeckl R, Marinov B, Pitta F: Practical recommendations for exercise training in patients with COPD .Eur Respir Rev 2013; 22: 178-186.
9. Dunne PJ: The clinical impact of new longterm oxygen therapy technology .Respir Care 2009; 54: 1100-1111.
10. Arlati S, Rolo J, Micallef E, Sacerdoti C, Brambilla I: A reservoir nasal cannula improves protection given by oxygen during muscular exercise in COPD .Chest 1988; 93: 1165-1169.
11. Claiborne RA, Paynter DE, Dutt AK, Rowlands JW: Evaluation of the use of an oxygen conservation device in long-term oxygen therapy .Am Rev Respir Dis 1987; 136: 1095-1098.
12. Gould GA, Hayhurst MD, Scott W, Flenley DC: Clinical assessment of oxygen conserving devices in chronic bronchitis and emphysema .Thorax 1985; 40: 820-824.
13. Moore-Gillon JC, George RJ, Geddes DM: An oxygen conserving nasal cannula .Thorax 1985; 40: 817-819.
14. Collard P, Wautelet F, Delwiche JP, Prignot J, Dubois P: Improvement of oxygen delivery in severe hypoxaemia by a reservoir cannula .Eur Respir J 1989; 2: 778-781.
15. Tiep BL, Burns M, Hererra J: A new pendant oxygen-conserving cannula which allows pursed-lips breathing .Chest 1989; 95: 857-860.
16. Hagarty EM, Skorodin MS, Stiers WM, Mamdani MB, Jessen JA, Belingon EC: Performance of a reservoir nasal cannula (Oxymizer) during sleep in hypoxemic patients with COPD .Chest 1993; 103: 1129-1134.
17. ATS ACCP: Statement on cardiopulmonary exercise testing .Am J Respir Crit Care Med 2003; 167: 211-277.
18. Gloeckl R, Halle M, Kenn K: Interval versus continuous training in lung transplant candidates: A randomized trial .J Heart Lung Transplant 2012; 31: 934-941.
19. van 't Hul A, Gosselink R, Kwakkel G: Constant-load cycle endurance performance: Testretest reliability and validity in patients with COPD .J Cardiopulm Rehabil 2003; 23: 143-150.
20. Borg GA: Psychophysical bases of perceived exertion .Med Sci Sports Exerc 1982; 14: 377-381.
21. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al: Standardisation of spirometry .Eur Respir J 2005; 26: 319-338.
22. Casaburi R: Factors determining constant work rate exercise tolerance in COPD and their role in dictating the minimal clinically important difference in response to interventions .COPD 2005; 2: 131-136.
23. O'Donnell DE, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, et al: Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD .Eur Respir J 2004; 23: 832-840.
24. Magnussen H, Paggiaro P, Schmidt H, Kesten S, Metzdorf N, Maltais F: Effect of combination treatment on lung volumes and exercise endurance time in COPD .Respir Med 2012; 106: 1413-1420.
25. O'Donnell DE, Casaburi R, Vincken W, Puente-Maestu L, Swales J, Lawrence D, et al: Effect of indacaterol on exercise endurance and lung hyperinflation in COPD .Respir Med 2011; 105: 1030-1036.
26. Marti S, Pajares V, Morante F, Ramon MA, Lara J, Ferrer J, et al: Are oxygen-conserving devices effective for correcting exercise hypoxemia? Respir Care 2013; 58: 1606-1613.